Top Canadian Cannabis Contenders: Stocks to Watch Before May 2024

Ahead of the Curve: Leading Canadian Cannabis Stocks for Early 2024

The global cannabis industry and top marijuana stocks are poised for significant growth, driven by increasing legalization and medical use. Furthermore, experts predict a compound annual growth rate of over 20% for the next decade. Consequently, this expansion benefits top Canadian companies such as Canopy Growth, Aurora Cannabis, and Aphria. These firms lead the market in innovation and distribution. Therefore, investors should closely monitor these names, as they could capitalize on global trends.

Recently, Canadian cannabis stocks have shown impressive performance, with several stocks making double-digit gains. This surge indicates a growing investor confidence in this sector. Moreover, technical analysis can help pinpoint trends and momentum in these stocks. Importantly, proper risk management is crucial; investors should set stop-loss orders to protect against volatility. By employing these strategies, investors can effectively maximize gains while minimizing potential risks.

[Read More] 3 Marijuana Stocks To Watch In Volatile Market 2024

May 2024 Watchlist: Key Players in the Canadian Cannabis Market

  1. Aurora Cannabis Inc. (NASDAQ: ACB)
  2. Canopy Growth Corporation (NASDAQ: CGC)

ACB  Aurora Cannabis Inc.

Aurora Cannabis Inc. is a key contender in the global cannabis market, renowned for its commitment to quality and innovation. Founded in 2006, Aurora has expanded its operations to include multiple facilities and research centers across Canada. They focus on developing cutting-edge technologies and cultivation techniques to produce a diverse range of cannabis products. These efforts position Aurora as a leader in both the medical and recreational cannabis sectors globally.


In the United States, Aurora has strategically positioned itself by acquiring Reliva, LLC, a leader in the sale of hemp-derived CBD products across thousands of retail locations. This acquisition marks Aurora’s significant entry into the U.S. market, aligning with its global expansion goals. Although not directly selling THC products in the U.S. due to federal restrictions, Aurora’s presence in the CBD sector helps it tap into the American market, leveraging Reliva’s established distribution network and consumer base.

Financial Highlights Fiscal 2024 Third Quarter

The press release for the third quarter of fiscal 2024 reveals Aurora’s financial and operational highlights, emphasizing a robust performance across various sectors. Consolidated revenue increased to $64.4 million from $61.1 million in the previous year, primarily fueled by growth in the global medical cannabis sector and a slight boost in plant propagation business. A decline in consumer cannabis revenue offset this. The adjusted gross profit saw a significant rise to $32.4 million, marking a 15.7% increase, with adjusted gross margins expanding to 50% from 46% last year. Medical cannabis continued to be a major contributor, accounting for 70% of the consolidated revenue and 86% of the adjusted gross profit, with notable sales increases in Australia and Europe due to new cultivar launches.

Operational efficiencies and strategic market positioning have led to a net loss reduction of $25.2 million from a larger loss of $62.4 million in the previous year, highlighting effective cost management and operational improvements. Adjusted EBITDA improved as well, reaching $4.3 million from $3.0 million. The company’s focus on high-margin markets, alongside enhanced production efficiencies, has been key in navigating the competitive landscape. Looking forward, Aurora anticipates steady revenue from its Canadian operations and modest growth in Europe and Australia, with expectations of continued positive adjusted EBITDA into the fourth quarter of 2024, reinforcing its path toward achieving positive free cash flow within the calendar year.

[Read More] Top U.S. Cannabis Stocks to Watch: Who’s Leading the Charge?

Canopy Growth Corporation

Canopy Growth Corporation, a leader in the global cannabis industry, is renowned for its commitment to excellence, creativity, and comprehensive customer experiences. The innovative business Canopy Growth is situated in Smiths Falls, Canada. Its rapid growth has been made possible by its dedication to producing high-quality cannabis products for both medicinal and recreational usage. Their business approach offers a wide selection of products, from dried cannabis flowers to cannabis oils, concentrates, and edibles, to satisfy the needs and preferences of a diverse clientele.

CGC marijuana stocks
From a strategic perspective, CGC has expanded its production and retail sites quickly, both domestically in Canada and internationally. In Canada, where government legalization has produced a conducive environment for the cannabis business to flourish, Canopy Growth is a well-known retailer. The company operates numerous retail locations under various names, including Tokyo Smoke and Tweed, two of its most well-known retail brands. CGC has purposefully navigated the complex legal landscape in the United States to establish a presence in key states with cannabis-friendly laws, such as Colorado and California. These states offer Canopy Growth crucial footholds in the burgeoning U.S. cannabis industry because they are not just sizable markets but also well-known for their cannabis cultures and trends.

Strategic alliances, acquisitions, and R&D projects have supplemented the company’s expansion activities, which intend to grow its product portfolio and strengthen its supply chain competencies. Canopy Growth seeks to improve cannabis customer experience and advance industry standards by emphasizing product innovation and consumer safety. Canopy Growth Corporation is in a strong position to take advantage of growth possibilities and solidify its position as the industry leader in the cannabis sector by utilizing its broad network, portfolio of brands, and innovation pipeline as the global cannabis market continues to change.

Financial Highlights

Canopy Growth Corporation reported substantial operational and financial metrics gains for Q3 FY2024. A notable improvement was observed across various performance indicators. The company’s combined gross margin reached 36%. Additionally, cannabis gross margins in Canada increased significantly. They rose to 28% from a negative 11% in Q3 FY2023.

This improvement is partly due to a 6% year-over-year rise in consolidated net revenue. This rise comes after adjusting for the sale of the Canadian national retail segment. Despite this increase, the net revenue of $79 million was 7% lower than the previous year. However, the company’s cannabis revenue outside of Australia surged by 81%. This surge was driven by strong growth in Australia, a rebound in Europe from new products, and improved sales execution.

The quarter’s performance was notably strong for Storz & Bickel®. Their net revenue soared by 54% sequentially. This increase was fueled by the brand’s most successful Black Friday sales event in 20 years. Additionally, strong sales of the new VENTY portable vaporizer contributed significantly.

Furthermore, CGC saw a $34 million improvement in free cash flow from ongoing operations compared to last year, marking a 57% increase. The company also reported a healthy balance of $186 million in cash and short-term investments. Meanwhile, total debt decreased by $69 million. During Q3 FY2024, management reaffirmed its goal to achieve positive Adjusted EBITDA in each business unit by year-end. CEO David Klein expressed optimism about the company’s growth and its focused strategy on cannabis across all business areas. He particularly noted how the Canopy USA proposal would offer unique access to the American cannabis market.

[Read More] April 2024’s Top Cannabis REITs for High Dividend Yields

Canadian Cannabis Stocks to Keep on Your Radar

As May 2024 approaches, investors should closely monitor top Canadian cannabis stocks such as Canopy Growth, Aurora Cannabis, and Tilray. These companies have consistently demonstrated strong market strategies and innovation. Particularly, their expansion efforts into international markets, including the U.S., make them intriguing prospects. Additionally, these companies have made significant strides in streamlining operations and enhancing production capabilities, positioning them well for future growth.

In the U.S., the cannabis industry is poised to expand significantly, with potential new state legalizations and federal reforms on the horizon. This expected growth offers a lucrative opportunity for Canadian companies operating in the American market. Investors can leverage technical analysis to identify buying opportunities and trends in these stocks. Moreover, implementing proper risk management, such as setting stop-loss orders and diversifying portfolios, is crucial. These strategies will help protect investments from the inherent volatility associated with the cannabis industry.

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like